Lin, Z., Li, H., He, C., Yang, M., Chen, H., Yang, X., . . . Xu, X. (2023). Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma. Frontiers in Oncology, 13, . https://doi.org/10.3389/fonc.2023.1072775
Chicago-referens (17:e uppl.)Lin, Zuyuan, et al. "Metabolomic Biomarkers for the Diagnosis and Post-transplant Outcomes of AFP Negative Hepatocellular Carcinoma." Frontiers in Oncology 13 (2023). https://doi.org/10.3389/fonc.2023.1072775.
MLA-referens (9:e uppl.)Lin, Zuyuan, et al. "Metabolomic Biomarkers for the Diagnosis and Post-transplant Outcomes of AFP Negative Hepatocellular Carcinoma." Frontiers in Oncology, vol. 13, 2023, https://doi.org/10.3389/fonc.2023.1072775.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
